(Q51832953)

English

Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases.

scientific article published on 19 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

Robert A. Olson

1

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

author name string

Scott Tyldesley

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

Hannah Carolan

3

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

Maureen Parkinson

4

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

Taruna Chhanabhai

5

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

Michael McKenzie

6

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

publication date

19 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

19

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

11

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

1849-1855

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

https://scigraph.springernature.com/pub.10.1007/s00520-010-1028-1

0 references

Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Incidence of brain atrophy and decline in mini-mental state examination score after whole-brain radiotherapy in patients with brain metastases: a prospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Symptom response after palliative radiotherapy for patients with brain metastases.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00520-010-1028-1

21 January 2018

Cognitive impairment and mortality: a study of possible confounders

1 reference

https://pubmed.ncbi.nlm.nih.gov/20957394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection bias introduced by neuropsychological assessments.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20957394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive functioning and quality of life in malignant glioma patients: a review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/20957394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20957394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/20957394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive function as a predictor of survival in patients with recurrent malignant glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20957394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20957394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The frequency and clinical course of cognitive impairment in patients with terminal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20957394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-010-1028-1

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/20957394

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51832953&oldid=1407316430"